Study: Drugs as good as stents

Score another point for drug therapy over stents. A new report shows that patients with chest pain but no emergency heart troubles do just as well on drugs as they would with implanted stents. Angioplasty did have a slight advantage on pain relief at first, but that shrank after six months and disappeared within three years.

This could be good news for patients--who wouldn't have to go through the procedure--along with payers, who have to shell out some $40,000 for angioplasty. Not to mention drugmakers. "This study should be enlightening and practice-changing," leading more to try drugs before stents, said Duke's Dr. Eric Peterson, who co-authored an editorial in the New England Journal of Medicine about the report.

- read the story in the Washington Post

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.